Somewhere between Ozempic and ayahuasca on the wellness spectrum, a new category has taken hold. People are injecting compounds with names like BPC-157, TB-500, and CJC-1295 — short chains of amino acids called peptides — in hopes of healing injuries faster, losing weight, sleeping better, reversing aging, and improving cognitive function. Gwyneth Paltrow has called peptide shots one of her “biggest wellness tools.” Joe Rogan credits BPC-157 with healing a shoulder injury. U.S. customs data shows imports of hormone and peptide compounds hit $328 million in the first three quarters of 2025 — double the same period in 2024.
The science has not kept pace. Not even close.
What Peptides Actually Are
The word “peptide” is doing a lot of heavy lifting in wellness marketing, and understanding why requires a brief detour into biology. Peptides are short chains of amino acids — the same building blocks that make up proteins, just smaller. The human body produces them naturally, and they play real roles in hormone signaling, immune function, and tissue repair. More than 100 FDA-approved drugs are peptide-based, including insulin and the active ingredients in GLP-1 medications like Ozempic and Wegovy.
That legitimate pharmaceutical pedigree is part of what makes the wellness peptide market so slippery to evaluate. The word “peptide” encompasses everything from rigorously tested, FDA-approved therapies to experimental compounds being injected by biohackers based on animal studies and influencer testimonials. The range between those two poles is enormous, and the marketing rarely acknowledges that it exists.
The Gray Market Problem
Most of the peptides generating buzz in wellness circles — BPC-157 for injury recovery, TB-500 for muscle growth and inflammation, GHK-Cu for skin and hair — have not been approved by the FDA and have not undergone rigorous clinical testing in humans. In 2023, the FDA moved 19 such peptides to a restricted list, citing safety concerns and lack of evidence. Compounding pharmacies could no longer legally prepare them.
The demand didn’t disappear. It went underground. “Gray market” peptides are now widely available online, labeled “for research purposes only” as a legal workaround, with many products sourced from Chinese manufacturers. Licensed clinic-based peptide therapy runs $250 to $1,000 per month. Gray market vials from overseas suppliers cost as little as $5 to $200 — with no pharmaceutical oversight, no dose verification, and no quality guarantee.
In February 2026, HHS Secretary Robert F. Kennedy Jr. announced that roughly 14 of the previously restricted peptides would be reclassified, allowing compounding pharmacies to prepare them again. The formal reclassification had not been published as of early April, leaving the regulatory landscape in an active state of flux.
What the Researchers Actually Say
The core scientific problem with most wellness peptides is straightforward: most of the research has been conducted in animals or laboratory settings, not humans. “There isn’t any meaningful data on these peptides,” said Dr. Eric Topol, a cardiologist and director of the Scripps Research Translational Institute. “People are taking them on blind faith.”
The animal research on some peptides is genuinely intriguing. Studies suggest BPC-157 may help with tissue repair by accelerating the growth of new blood vessels — which is why injured athletes find it appealing. But Paul Knoepfler, a cell and molecular biologist at UC Davis, notes the same mechanism could theoretically accelerate the growth of precancerous cells. The same substance that repairs tissue in one context may behave very differently in another, at a different dose, in a human body rather than a rodent.
“You can’t just make up what dose to take,” Knoepfler told NPR. “There’s often no apparent rhyme or reason to the wellness peptide doses people are taking.”
The Pattern Is Familiar
Peptides follow a well-worn path in wellness culture: a grain of legitimate science, amplified by high-profile endorsements, distributed through channels that operate outside regulatory oversight, and consumed by people who are genuinely seeking solutions that conventional medicine hasn’t provided. The appeal is real. The evidence gap is also real.
What makes peptides different from previous wellness crazes is the scale and the delivery method. These aren’t supplements to swallow — many are injected. The gray market supply chain runs through overseas manufacturers with no accountability to American pharmaceutical standards. And the regulatory moment is genuinely unsettled, with a health secretary who has publicly expressed skepticism toward the FDA’s approach to alternative therapies now in a position to reshape the rules.
For anyone considering peptides, the consistent advice from physicians and researchers is the same: consult a doctor before starting, purchase only from licensed compounding pharmacies rather than online gray market sources, and apply significant skepticism to any claim of universal benefit. As one physician summarized it: “Peptides may be useful tools in select clinical contexts, but claims of universal rejuvenation are ahead of the evidence.”